Aims Previous studies revealed that d70% or <30% ST segment elevation resolution 180 min after the start of thrombolysis is a strong predictor of either favourable or poor outcome. The aim of this study was to compare the prognostic value of ST segment elevation resolution at 90 and 180 min after the start of streptokinase infusion
Introduction
In patients with evolving myocardial infarction the strong prognostic power of ST segment elevation resolution varies according to its extent [1, 2] . These studies showed that d70% ST segment elevation resolution 180 min after initiation of thrombolytic therapy is best at predicting small infarcts and preserved left ventricular function, while <30% ST segment elevation resolution predicts an increased mortality risk. In comparative trials of thrombolytic therapy ST segment elevation resolution of varying extent may also provide a sensitive measure of clinical benefit and may serve as a surrogate for improved survival [2] . The optimal cut-off point at 30% ST segment elevation resolution for prediction of an increased mortality risk had been assessed by appropriate statistical methods. Less than 30% ST segment elevation resolution 180 min after the start of thrombolytic therapy was a most powerful independent predictor of early mortality [1, 2] . Patients with persistent occlusion of the infarct-related artery, as suggested by <30% ST segment A complete list of collaborators and participating centres is given in ref [3] . elevation resolution, may benefit from rescue angioplasty. However, since in order to salvage jeopardized ischaemic myocardium shortening of the ischaemic time is critical, earlier identification of unsuccessful reperfusion is desirable.
In conjunction with the Hirudin for Improvement of Thrombolysis (HIT)-4 study [3] we conducted a substudy to compare the prognostic impact of ST segment elevation resolution at 90 and 180 min after the start of therapy. Comparison of the treatment groups by the extent of ST segment elevation resolution, which served as a secondary HIT-4 trial end-point, will be discussed elsewhere [3] .
Methods
The HIT-4 study was a multicentre, double-blind randomized trial that compared streptokinase therapy in conjunction with either r-hirudin or heparin in patients within 6 h of onset of acute myocardial infarction [3] . The primary objective was to demonstrate higher 90 min infarct-related coronary artery patency rates with r-hirudin in a subset of about 400 patients, in whom early angiography had been performed [4] . Patients older than 18 years were eligible for randomization if they had no clear contraindication to thrombolytic therapy and in whom ST segment elevation was d0·1 mV in at least two limb leads or d0·2 mV in two contiguous chest leads or bundle branch block was present.
Study patients
All 1208 patients recruited for the HIT-4 study were considered for analysis. A 12-lead ECG was recorded before, at 90, and 180 min after the start of the streptokinase infusion. Evaluation was performed centrally, independent of and blinded to the other study data or results.
In 140 patients the pre-randomization ECG (ECG 1) was not compatible with the evaluation of the predictive power of ST segment elevation resolution: one patient had idioventricular rhythm; in two, ECGs were recorded after the start of the streptokinase infusion; 13 patients had no streptokinase infusion; 43 patients (including eight with bundle branch block) had no ischaemic ST segment elevation; and 81 (40 patients with anterior and 41 with inferior ischaemia) did not show the required amount of ST segment elevation. Of these 140 patients four died before day 30, three from cardiac causes.
For various reasons, an additional 164 patients were excluded from the 90 min ECG (ECG 2) evaluation, and 70 from the 180 min ECG (ECG 3) evaluation, mostly because the ECGs were recorded outside the respective time windows (Table 1) . Thus, 904 (445 allocated r-hirudin, 459 heparin) and 998 (500 allocated r-hirudin, 498 heparin) patients formed the basis for the 90 and 180 min evaluations, respectively.
From selected hospitals, 447 randomized patients (37% of the total study population) were included into the angiographic substudy (angio patients) of the HIT-4 trial [4] . Baseline characteristics, including time to treatment, were not different between the angio and nonangio patients. Details are reported elsewhere [3] . Incidence and reasons for exclusion from ST segment elevation resolution evaluation were similar in patients enrolled in the angio and non-angio part of the study. Thus, ST segment elevation resolution evaluation at 90 and 180 min includes 36% and 37% of angio patients. Because ST elevation recovery between 90 and 180 min in patients who had an occluded artery at 90 min was not different in patients with or without rescue angioplasty, no patients were excluded from evaluation of the ECG recorded at 180 min. Selective exclusion of a cohort with occluded arteries would have caused more bias.
All serious adverse events including death (and causes of death), reinfarction, and refractory angina pectoris were validated by an End-point Validation Committee. Refractory angina pectoris was defined as recurrent chest pain (with documented ST-T changes during periods of pain) under 'optimal' medical treatment requiring either emergency catheterization, repeated thrombolysis or transfer to a tertiary centre within 24 h.
Electrocardiographic analysis
The sum of ST segment elevation was measured with lens-intensified callipers to the nearest 0·025 mV 20 ms for inferior infarction were added [2] . A large anterior infarction was defined by the sum of ST elevation >1·2 mV on the baseline ECG or the presence of bundle branch block; a large inferior infarction by presence of precordial ST segment depression of d0·1 mV in at least two V 1 -V 4 leads, or the sum of ST elevation >0·8 mV or the presence of bundle branch block.
Prognostic ST segment resolution groups
Consistent with previous studies [1, 2] three categories of ST segment elevation resolution were applied: complete resolution was defined as d70% ST segment elevation resolution; partial resolution was defined as ST segment elevation resolution <70% to 30%; no resolution was defined as ST segment elevation resolution <30% to d0%. For the 90 min ECG recording, a time window of 70 to 110 min after initiation of thrombolytic therapy was allowed. The time window for the 180 min ECG recording was 120 min to 240 min, as in previous studies [2] .
Statistical analysis
For univariate analyses only non-parametric methods were applied. For comparisons of two dependent/ independent samples, Wilcoxon signed rank tests/ Mann-Whitney U tests or Fisher's exact test were applied. For comparisons of three or more independent samples we used Kruskal-Wallis tests.
To assess the optimal ST segment elevation resolution cut-off point that best predicts an increased mortality risk, the squared standardized log odds ratio statistic was applied [5, 6] . As a function of the hypothetical cut-off points for the sum of ST segment elevation resolution it measures the differences in mortality rates on either side of the cut-off points in each sample of ST segment elevation resolution between 100% to less than 0%. The optimal cut-off point corresponds to the maximum squared log odds ratio.
The multivariate analysis consisted of stepwise logistic regression for outcome at 30 days ( =0·05). Eleven variables were offered as covariates: (1) age (taken as a continuous variable, in units of 10 years); (2) female gender; (3) history of heart failure; (4) previous infarction; (5) diabetes mellitus; (6) history of angina pectoris; (7) ex-smoker or non-smoker; (8) anterior infarction; (9) Killip class >1; (10) large sum of ST segment elevation on the pre-randomization ECG, and (11) treatment with r-hirudin. In a second analysis ST segment elevation resolution was added as potential covariate.
Logistic regression was performed using the procedure 'LOGISTIC REGRESSION' of SPSS for Windows, version 6.1.3, the forward-stepping selection method with ML estimates and the default criteria offered by SPSS. The odds ratio, confidence intervals and P values of the final model (i.e. adjusted for all other significant covariates) are reported.
Results
The time interval from the start of the streptokinase infusion to the 90 min ECG recording for the groups with complete, partial, and no ST segment elevation resolution was median (25th, 75th percentiles) 89 (81, 91), 90 (83, 92), and 89 (81, 91) min. The corresponding times with the 180 min ECGs were 180 (176, 186), 180 (175, 185), and 180 (175, 190) min, respectively. The sum of ST elevation at baseline decreased in the complete ST segment elevation resolution group from 0·85 (0·55, 1·39) mV to 0·10 (0·00, 0·023) mV at 90 min, and from 0·90 (0·58, 1·40) mV to 0·10 (0·00, 0·23) mV at 180 min.
The corresponding values for the partial ST segment elevation resolution group were 0·95 (0·60, 1·41) to 0·48 (0·30, 0·70) mV at 90 min, and from 1·05 (0·73, 1·58) to 0·48 (0·30, 0·70) mV at 180 min. The sum of the ST elevation increased in the no ST segment elevation resolution group from median 0·98 (0·63, 1·55) to 1·03 (0·68, 1·7) mV at 90 min, and from 0·85 (0·55, 1·43) to 0·90 (0·58, 1·48) mV at 180 min.
Baseline characteristics of the three ST segment elevation resolution group patients are presented in Table 2 . There were no differences within the three ST segment elevation resolution groups whether the ECGs were recorded at 90 min or at 180 min. Patients who had complete ST segment elevation resolution were younger, and in current smokers the proportion of patients was larger with complete ST segment elevation resolution and smaller with no ST segment elevation resolution. The proportion of patients with anterior infarction (vice versa for inferior infarction) and of diabetics was smaller in the complete ST segment elevation resolution groups and larger in the no ST segment elevation resolution groups. There was a small trend towards less complete and more no ST segment elevation resolution in patients enrolled in the angio part of the study. Rescue angioplasty after the 90 min angiogram was performed in 77 of 131 patients who had a TIMI grade flow 0 or 1 (8% of the total cohort of 998 patients). They also tended to have less ST segment elevation resolution at 180 min as compared to spontaneous ST elevation recovery in patients managed conservatively, and also survival had not improved (seven deaths vs two in patients without angioplasty).
The intensity of ischaemia, as assessed by the sum of ST elevation at baseline, was not different between the 90 min ST segment elevation resolution groups, but as in the previous studies [1, 2] there was a trend towards a lower sum of baseline ST elevation in the 180 min no ST
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segment elevation resolution group. Times from symptom onset to streptokinase infusion were shorter for the complete ST segment elevation resolution groups both at 90 and 180 min. Time differences between the three ST segment elevation resolution groups at 180 min were statistically significant.
At 90 min after the start of the streptokinase infusion 25% of patients had complete, 31% partial and 44% no ST segment elevation resolution as compared to 50%, 35%, and 15%, respectively, at 180 min. Figure 1 shows the percentage of patients who had either complete, partial or no ST segment elevation resolution at 90 min or at 180 min, respectively, and the proportion of changes from 90 to 180 min in 866 patients with ECGs evaluated both at 90 and 180 min. Of 220 patients who had complete ST segment elevation resolution at 90 min, only three deteriorated to no ST segment elevation resolution and 13 to partial ST segment elevation resolution. Of 272 patients who had partial ST segment elevation resolution at 90 min 138 improved to complete ST segment elevation resolution (two died), 118 remained in the partial ST segment elevation resolution group, and 16 deteriorated to no ST segment elevation resolution. Of 374 patients with no ST segment elevation resolution at 90 min, 79 improved to complete ST segment elevation resolution at 180 min (one died), 171 to partial ST segment elevation resolution, and only 124 remained in the no ST segment elevation resolution group at 180 min.
Clinical event rates
Various cardiac event rates subdivided by the three ST segment elevation resolution groups are displayed in Table 3 . Cardiogenic shock and severe heart failure were observed more often with no ST segment elevation resolution, both for the groups with ECGs recorded at 90 and 180 min. Complete ST segment elevation resolution was associated with a trend to a higher incidence of recurrent serious ischaemic events, i.e. reinfarction and refractory angina pectoris. In relation to ECGs recorded at 180 min, the occurrence of recurrent infarction in 31 patients and re-ischaemia in 80 patients was observed within the first week of the index infarction.
Thirty day mortality rates
Total mortality in the entire HIT-4 study population was 80 out of 1208 (6·6%) patients, of whom 10 or 14, respectively, died early before a 90 or 180 min ECG could be recorded (Table 1) . Total mortality occurred in 50 of 904 (5·5%) patients who had an ECG recorded at 90 min, and in 57 of 998 (5·7%) patients with an ECG recorded at 180 min. For the three ST segment elevation resolution groups (complete, partial and no ST segment elevation resolution) with 90 min ECGs, mortality rates were 1·8%, 4·2%, and 8·6%, respectively, and at 180 min 2·8%, 6·0%, and 14·3%. The optimal ST segment elevation resolution cut-off point that best predicts an increased mortality risk, i.e. 30% ST segment elevation resolution, was confirmed by the standardized log odds ratio statistics for ST segment elevation resolution at 180 min, while no clear cut point for prediction of mortality could be assessed for ST segment elevation resolution at 90 min. Causes of death are given in Table 4 . Death due to cardiac failure or cardiac rupture was more often associated with no ST segment elevation resolution. There was no difference between the three ST segment elevation resolution groups in the incidence of arrhythmia deaths and death due to recurrent infarction. A relatively large number of patients suffered non-cardiac deaths, particularly in the complete ST segment elevation resolution groups (two cerebral haemorrhage, two ischaemic stroke with haemorrhage conversion, two ruptured aortic aneurysm, and one of each haematothorax, spleen rupture after resuscitation outside hospital, pulmonary embolism, colon carcinoma, pancreatitis, Leriche-syndrome). Since differences in ST segment elevation resolution are not expected to predict non-cardiac mortality, cardiac mortality rates for various subgroups are reported in Tables 5 and 6 . With complete ST segment elevation resolution on the 90 min ECG the cardiac mortality rate was very low, and only slightly higher at 180 min. The high risk group defined by no ST segment elevation Table 2 .
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resolution on the 90 min ECG consists of 44% of all patients with a 7·3% cardiac mortality risk that accounts for 71% of all cardiac deaths, while with no ST segment elevation resolution at 180 min 15% of all patients were identified who carry a 13·6% cardiac mortality risk, which still accounts for 45% of all cardiac deaths. For all subgroups including those with a large inferior infarction (among 137 patients with a small inferior infarction four patients died but only one had suffered cardiac death) mortality rates with no ST segment elevation resolution on the 180 min ECG were about twice as high as those with no ST segment elevation resolution at 90 min. When ST segment elevation resolution was not added, multivariate logistic regression analysis revealed five covariates that were independent predictors of 30 day mortality (Table 7A) . After ST segment elevation resolution was added to the model, only age, ST segment elevation resolution at 180 min and Killip class >1 were selected (Table 7B) . ST segment elevation resolution at 90 min was not selected.
Discussion
In concordance with the previous studies, about 50% of all patients have complete ST segment elevation resolution 180 min after the start of streptokinase therapy [1, 2] . These patients have 30 day cardiac mortality rates below 2% [2] . Likewise confirmed is a high early mortality in patients who had no (<30%) ST segment elevation resolution. In all three studies multivariate analyses revealed ST segment elevation resolution at 180 min as a most powerful independent predictor of early mortality. Tables 2 and 5 .
Mortality predicted by ST resolution at 90 or 180 min
Complete ST segment elevation resolution at 90 min after initiation of thrombolysis is associated with very low cardiac mortality (Table 5 ). Of note, only a few patients deteriorated to partial or no ST segment elevation resolution at 180 min. Thus, excellent survival can be predicted for about one quarter of all patients already 90 min after the start of therapy. However, with ECGS recorded at 90 min there was a more continuous increase in mortality in relation to decreasing ST segment elevation resolution. In contrast, with ECGs recorded at 180 min mortality sharply increased at around 30% ST segment elevation resolution such that no ST segment elevation resolution strongly predicts an increased mortality risk. While the mortality rates doubled, the proportion of patients with no ST segment elevation resolution had decreased by two-thirds from 90 to 180 min. On the other hand, at the expense of an only marginally higher mortality, the percentage of patients with complete ST segment elevation resolution had increased from 25% at 90 min to one half of all patients at 180 min. The changes in ST segment elevation resolution between 90 and 180 min are consistent with recanalization of the infarct vessel later than 90 min after the start of streptokinase therapy in a significant proportion of patients [7] . Persistent ST elevation at 180 min, however, suggests definite failed reperfusion. Hence, no ST segment elevation resolution at 180 min is associated with the highest mortality risk.
Mechanisms involved in the ST resolution process
Reperfusion of an occluded infarct-related coronary artery is the principal mechanism by which thrombolytic therapy improves survival [8] . A lower mortality risk in younger patients and in smokers coincides with better early reperfusion rates [9, 10] , and is associated with better ST elevation recovery (Table 2 ). On the other hand, poor ST elevation recovery and higher mortality rates in anterior infarction as compared to inferior infarction, and in diabetic compared to non-diabetic patients cannot be explained by lower rates of early infarct artery recanalization. The 90 min patency rates had been found to be similar in these patient groups [11] [12] [13] [14] . Since in both, patients with anterior and inferior infarction larger infarct sizes were associated with more complete and less no ST resolution, the responsible mechanism for less ST elevation recovery in anterior infarction apparently is not a larger infarct size. After ST segment elevation resolution had been added to the model as an additional variable in the multivariate analysis, anterior infarction was eliminated as an independent predictor of mortality (Table 7) . Thus, the higher mortality risk associated with anterior infarction appears to be represented by worse ST elevation recovery.
Complete ST segment elevation resolution 90 min post streptokinase in the angio patients predicted simultaneous vessel patency (TIMI grade 2 or 3 flow) in 92% of patients; only a few patients who had an occluded infarct artery showed complete ST segment elevation resolution (96% sensitivity for TIMI 0 or 1, and 90% for TIMI 0-2). None of these patients died. Effective collateral circulation may have attenuated myocardial ischaemia [15] . Despite vessel patency, however, a considerable number of patients had only partial or even no ST segment elevation resolution [4] . After successful recanalization of the epicardial vessel by primary angioplasty ST segment elevation likewise often persists and is associated with the development of larger infarcts [16, 17] . ST segment changes in evolving myocardial infarction reflect the existing ischaemic myocardial injury [18] . Despite achievement of epicardial vessel patency, in most patients microvascular damage impedes myocardial blood supply at least to some extent [19, 20] . The spectrum of reperfusion at the myocardial level ranges from no Table 2 .
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reflow or partial reperfusion to normal perfusion [19] . Anterior wall infarction appears to be more prone to myocardial no-reflow than inferior wall infarction [16, 17, 19, 20] . ST segment changes in evolving myocardial infarction reflect myocardial flow rather than epicardial flow, and hence predict outcome better than the patency status of the epicardial vessel alone.
Study limitations
For various reasons a relatively large number of patients were excluded from the evaluation of the prognostic power of ST segment elevation resolution ( Table 1) . Inclusion of all patients for whom an ECG was recorded outside the stipulated time window did not change the results: total mortality for complete, partial and no ST segment elevation resolution at 90 min is 2·1%, 4·3%, and 8·8%, and 2·6%, 6·4%, and 14·3% at 180 min, respectively. Assuming, in addition, that all patients for whom ECGs were not available for evaluation (idioventricular rhythm, pacemaker or ECG missing) would have had no ST segment elevation resolution, the calculated total mortality would account for 10·6% with no ST segment elevation resolution at 90 min (eight additional deaths), and 16·2% with no ST segment elevation resolution at 180 min (three additional deaths). Exclusion of patients did not fundamentally influence the results.
Clinical implication
In patients with evolving myocardial infarction, resolution of ST segment elevation provides readily available and reliable prognostic information. Although standard ECGs 90 or 180 min after the start of streptokinase therapy are just snapshots of an ongoing and sometimes undulating process, the extent of ST segment elevation resolution can be used for early risk stratification. A major subset of patients with an excellent survival can be identified early on by complete ST segment elevation resolution. In these patients, more conservative management may be favoured. However, these patients carry a slightly higher probability of non-fatal reinfarction and recurrent 'refractory' angina pectoris, particularly during the first week after infarction. In the high risk subset identified by no ST segment elevation resolution at 180 min, more aggressive treatment strategies including rescue angioplasty may be considered. A 90 min strategy of rescue angioplasty, when streptokinase is used, will expose many patients unnecessarily to the risk inherent to the invasive procedure. For early clinical decision making it appears of particular value that even among the high risk patient groups, (e.g. those with large anterior infarction, older age or Killip class >1 on admission) complete ST segment elevation resolution identifies individuals with a relatively good, and no ST segment elevation resolution those with an exceptionally unfavourable prognosis.
